Birinapant (TL32711): Mechanism of Action

Birinapant (TL32711) MOA:Targeting cIAP1/NF-κB Pathway for Oncology Research

🎯 check Birinapant (TL32711) product page

Birinapant is a potent pan-IAP antagonist. It affects NF-κB and apoptotic signaling by promoting cIAP auto-ubiquitylation and degradation, effectively inducing apoptosis and inhibiting tumor cell viability.

Primary Applications and Mechanism of Action